Academic literature on the topic 'Interleuchina 1'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Contents
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Interleuchina 1.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Interleuchina 1"
De Ferrari, Gaetano Maria, Andreis, Alessandro, and Imazio, Massimo. "nibizione della Interleuchina-1 nella pericardite ricorrente refrattaria." Cardiologia Ambulatoriale, no. 3 (January 21, 2020): 212–22. http://dx.doi.org/10.17473/1971-6818-2019-3-7.
Full textDissertations / Theses on the topic "Interleuchina 1"
Mattioli, Benedetta <1980>. "Ruolo di interleuchina-33 sull'espressione di geni profibrotici e sull'ipertrofia dei miofibroblasti nella fibrosi intestinale." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2011. http://amsdottorato.unibo.it/4219/1/Mattioli_Benedetta_tesi.pdf.
Full textPastorelli, Luca <1977>. "Espressione e ruolo funzionale di interleuchina-33 e del suo recettore, ST2, nelle malattie infiammatorie croniche intestinali." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2011. http://amsdottorato.unibo.it/4148/1/pastorelli_luca_tesi.pdf.
Full textLiguori, Giuseppina <1980>. "Ruolo della Interleuchina-6 nella colite ulcerosa long-standing: regolazione della p53 ed induzione delle cellule mesenchimali epiteliali." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2013. http://amsdottorato.unibo.it/5660/1/liguori_giuseppina_tesi.pdf.
Full textChronic inflammation is an established risk factor of the onset of cancer, and the inflammatory cytokine IL-6 has been proved to play a role in tumorigenesis. Here we showed that IL-6 down-regulates the expression and activity of the tumor suppressor p53. In human cell lines, IL-6 enhanced rRNA transcription by stimulating c-myc protein expression at post-transcriptional level in a p38MAPK-dependent manner. The up-regulated ribosome biogenesis reduced the p53 expression through the activation of the ribosomal protein-MDM2 degradation pathway of p53. The p53 down-regulation induced cells to acquire phenotypic and functional changes characteristic of the epithelial-mesenchymal transition, a process associated with malignant transformation and tumor progression. We found that these changes also occurred in the colon epithelial cells of patients with ulcerative colitis, a very representative example of a chronic inflammation prone to neoplastic transformation, and disappeared after treatment with anti-inflammatory drugs. These findings unraveled a new IL-6 induced oncogenic effect which can greatly contribute to increase the risk to develop cancer not only in patients with chronic inflammations, but also in patients with those pathological conditions which are characterized by high IL-6 plasma level, such as obesity and type-2 diabetes mellitus.
Sansone, Pasquale <1981>. "The role of interleuchin 6 (IL-6) in the promotion of an aggressive and stem cell-like phenotype in human breast cancer cells and in stem/progenitor cells expanded in vitro as mammospheres." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2009. http://amsdottorato.unibo.it/2087/1/sansone_pasquale_tesi.pdf.
Full text